These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10427136)

  • 1. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
    Lucci A; Giuliano AE; Han TY; Dinur T; Liu YY; Senchenkov A; Cabot MC
    Int J Oncol; 1999 Sep; 15(3):535-40. PubMed ID: 10427136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Int J Oncol; 1999 Sep; 15(3):541-6. PubMed ID: 10427137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
    Lavie Y; Cao Ht; Volner A; Lucci A; Han TY; Geffen V; Giuliano AE; Cabot MC
    J Biol Chem; 1997 Jan; 272(3):1682-7. PubMed ID: 8999846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
    J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide glycosylation potentiates cellular multidrug resistance.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of glucosylceramides in multidrug-resistant cancer cells.
    Lavie Y; Cao H; Bursten SL; Giuliano AE; Cabot MC
    J Biol Chem; 1996 Aug; 271(32):19530-6. PubMed ID: 8702646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.
    Gouazé V; Yu JY; Bleicher RJ; Han TY; Liu YY; Wang H; Gottesman MM; Bitterman A; Giuliano AE; Cabot MC
    Mol Cancer Ther; 2004 May; 3(5):633-9. PubMed ID: 15141021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
    Vickers PJ; Dickson RB; Shoemaker R; Cowan KH
    Mol Endocrinol; 1988 Oct; 2(10):886-92. PubMed ID: 3185565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein.
    Goulding CW; Giuliano AE; Cabot MC
    Cancer Lett; 2000 Feb; 149(1-2):143-51. PubMed ID: 10737718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells.
    Gutiérrez-Iglesias G; Hurtado Y; Palma-Lara I; López-Marure R
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):809-17. PubMed ID: 25113261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
    Cabot MC; Giuliano AE; Han TY; Liu YY
    Cancer Res; 1999 Feb; 59(4):880-5. PubMed ID: 10029079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
    Chapman JV; Gouazé-Andersson V; Karimi R; Messner MC; Cabot MC
    Exp Cell Res; 2011 Jul; 317(12):1736-45. PubMed ID: 21396934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells.
    Sun YL; Zhou GY; Li KN; Gao P; Zhang QH; Zhen JH; Bai YH; Zhang XF
    Neoplasma; 2006; 53(1):1-8. PubMed ID: 16416005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide synthesis and metabolism as a target for cancer therapy.
    Reynolds CP; Maurer BJ; Kolesnick RN
    Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance.
    Ogretmen B; Hannun YA
    Drug Resist Updat; 2001 Dec; 4(6):368-77. PubMed ID: 12030784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis.
    Liu YY; Han TY; Giuliano AE; Ichikawa S; Hirabayashi Y; Cabot MC
    Exp Cell Res; 1999 Nov; 252(2):464-70. PubMed ID: 10527636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.